Intrinsiqq
NextCure, Inc. logo

NextCure, Inc. Intrinsic Value

NXTC

Compare

NextCure fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for NextCure today, so there is nothing to project yet.

SourceFair value computed from the 10-Q filed 9 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 10 Nov 2026. How this is calculated.

Price from market data, last close as of 20 Nov 2026. Fiscal year ends Dec.

Peers

Pharmaceutical Preparations · Pick stocks to compare with NXTC

CompareIntrinsic value
PRLDPrelude Therapeutics Incorporated
$3.23-0.77%46
CAPRCapricor Therapeutics Inc.
$7.59+0.80%10
JANXJanux Therapeutics Inc.
$10.08-2.04%40
QUREuniQure N.V.
$19.35-4.35%10
BGMBGM Group Ltd.
$8.00+0.00%10
SLGLSol-Gel Technologies Ltd.
$55.17+2.02%65
SCYXScynexis, Inc.
$2.38-8.64%40
NAMSNewAmsterdam Pharma Co. N.V.
$18.41-5.64%10

Spot a number that looks wrong? Check it in NXTC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing NXTC

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.